title: Aurora kinase inhibitor ZM447439 induces apoptosis via mitochondrial pathways.
abstract: ZM447439 (ZM) is a potent and selective inhibitor of aurora-A and -B kinase with putative anti-tumoral activity. Inhibitors of aurora kinases were shown to induce apoptosis in vitro and in vivo. To investigate the underlying mechanisms, cell death pathways triggered by ZM was analysed in HCT-116 colorectal cancer cells. Through correlation of polyploidization and apoptosis in different knockout cells, the interrelation of these cellular responses to ZM was investigated. ZM induced apoptosis in a concentration- and time-dependent manner. ZM-induced apoptosis was associated with an upregulation of p53, breakdown of the mitochondrial membrane potential (DeltaPsim) and activation of caspase-3. To precisely define key components for ZM-induced apoptosis, knockout cells lacking p53, Bak, Bax or both Bak and Bax were used. Lack of p53 reduced ZM-induced apoptosis and breakdown of DeltaPsim, while lack of Bak, Bax or both almost completely inhibited apoptosis and breakdown of DeltaPsim. Since no difference in apoptosis induction was detectable between HCT-116 cells lacking Bak, Bax or both, apoptosis induction depended non-redundantly on both Bak and Bax. Phenomenally, ZM induced notable polyploidization in all examined cells, especially in p53-/- cells. A correlation between polyploidization and apoptosis was observed in wild-type, and also in p53-/- cells, albeit with a modest extent of apoptosis. Moreover, in Bak-/-, Bax-/- and Bak/Bax-/- cells apoptosis was totally inhibited in spite of the strongest polyploidization, suggesting apoptosis may be a secondary event following polyploidization in HCT-116 cells. Thus ZM-induced apoptosis depends not only on polyploidization, but also on the intracellular apoptotic signaling.
authors.affiliation: Department of Radiation Oncology, University Hospital Munich, Germany.
authors.forename: Minglun
authors.initials: M
authors.lastname: Li
authors.forename: Anke
authors.initials: A
authors.lastname: Jung
authors.forename: Ute
authors.initials: U
authors.lastname: Ganswindt
authors.forename: Patrizia
authors.initials: P
authors.lastname: Marini
authors.forename: Anna
authors.initials: A
authors.lastname: Friedl
authors.forename: Peter T
authors.initials: PT
authors.lastname: Daniel
authors.forename: Kirsten
authors.initials: K
authors.lastname: Lauber
authors.forename: Verena
authors.initials: V
authors.lastname: Jendrossek
authors.forename: Claus
authors.initials: C
authors.lastname: Belka
mesh_terms: D017209:Apoptosis / Q000187:drug effects*; D064127:Aurora Kinases; D001549:Benzamides / Q000494:pharmacology*; D045744:Cell Line, Tumor; D005434:Flow Cytometry; D006801:Humans; D008928:Mitochondria / Q000378:metabolism*; D047428:Protein Kinase Inhibitors / Q000494:pharmacology*; D017346:Protein Serine-Threonine Kinases / Q000037:antagonists & inhibitors*; D011799:Quinazolines / Q000494:pharmacology*
chemical_list: C474722:4-(4-(N-benzoylamino)anilino)-6-methoxy-7-(3-(1-morpholino)propoxy)quinazoline; D001549:Benzamides; D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D064127:Aurora Kinases; D017346:Protein Serine-Threonine Kinases